Prevalence of bacterial resistance with diabetic foot patients in MMC

Mohamed Eshlak; Eltaher Elshagmani; Taher Alkesa; Omar Broween

المؤلفون

Mohamed Eshlak Dept of Microbiology Faculty of Medical Technology- Misrata, Libya
Eltaher Elshagmani Dept of Microbiology at National Cancer Institute- Misrata, Libya
Taher Alkesa Dept at general surgery at Misrata Medical Center (MMC)-Misrata, Libya
Omar Broween Dept of Microbiology Faculty of Medical Technology- Misrata, Libya

الكلمات المفتاحية:

Diabetic foot infections، antimicrobial profiles، multi-drug resistant

الملخص

Diabetic patients may experience a variety of complications, including immunodeficiency, blood ischemia and microbial infections, which can increase the risk of diabetic foot wounds becoming chronic and difficult to treat. Diabetic foot patients are subjected to long periods of antimicrobial therapy, which leads to an increase in antibiotic-resistant strains. Multidrug resistance organisms have spread throughout the world in diabetic foot infections (DFIs). This type of infection requires prompt and effective antimicrobial therapy to reduce the complications associated with such infections. The detection rate and identification of common microbial pathogens, as well as their antimicrobial susceptibility patterns, were the focus of this study in DFIs. Forty swabs (specimens) were collected from none repeated diabetic foot patients attending MMC for medical services. Standard microbiological methods were used to identify microbial pathogens. The Clinical and Laboratory Standards Institute's standard guidelines were used to determine antimicrobial susceptibility testing and resistant profiles (CLSI). According to the study's findings, bacterial growth was found in 80 % of the specimens. Staphylococcus aureus (30%) and Pseudomonas aeruginosa (22.5%) were the most frequently isolated bacterial pathogens. Gram-positive isolates were generally highly sensitive to Cefuroxime (72%), Azithromycin (61%), and Clindamycin (57 %). There was a high MRSA prevalence (75 %). The majority of Gram-negative isolates were susceptible to Azithromycin (63%) and Amikacin (59%), but highly resistant to Augmentin (81%) and Ceftriaxone (63%). DFIs are common cases in MMC's surgery OPD, and the majority of them are associated with multi-drug resistant strains.

المراجع

Ndip RN, Takang AEM, Echakachi CM, Malongue A, Akoachere J-FTK: In vitro antimicrobial activity of selected honeys on clinical isolates of Helicobacter pylori. Afr Health Sci 2007, 7(4):228–231.

Stewart, M. G. Principle of ballistic and penetrating trauma. Comprehen. Managem. 2005,188-194.

Siddiqui, A., Bernstein, J. Chronic wound infection: facts and controversies. Clin. Dermatol. 2010, 28: 516-526.

Arabishahi, K. S., Koohpayezade, J. Investigation of risk factors for surgical wound infection among teaching hospital in Tehran. Int. wound Journal. 2006, 3: 59-62.

Kotisso, B.; Aseffa, A. Surgical wound infection in a Teaching Hospital in Ethiopia, Est. Afr. Med J. 1998, 75: 402-406.

AK Pappu, A Sinha, A Johnson. Microbiological profile of diabetic foot ulcer. Calicut Med Journal. 2011;9(3): e1–4.

S Shakil, AU Khan. Infected foot ulcers in male and female diabetic patients: A clinico-bioinformative study. Ann ClinMicrobiolAntimicrob. 2010; 9:1–10

DM Citron, EJC Goldstein, VC Merriam, BA Lipsky. Bacteriology of moderate to severe diabetic foot infections and invitro activity of antimicrobial agents. J ClinMicrobiol. 2007;45(9):2819–28.

Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E, Infectious Diseases Society of America: Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.Clin Infect Dis 2012, 2012:e132–e173.

Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA: Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.JClinMicrobiol 2007, 45:2819–2828.

Roberts AD, Simon GL: Diabetic foot infections: the role of microbiology and antibiotic treatment.SeminVascSurg 2012, 25:75–81.

Adepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R, et al. Aclinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care. 2006; 29:1727–32.

Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA, et al. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006; 29:1288–93.

CLSI, Performance Standards for Antimicrobial Disk Susceptibility Tests, Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2018.

N Ahmed. (2005). Advanced glycation end products--role in pathology of diabetic.

AS Hayat, A H Khan., N Masood, N Shaikh, 2011. Study for microbiological pattern and in vitro antibiotic susceptibility in patients having diabetic foot infections at Tertiary Care Hospital in Abbottabad. World Appl. Sci. J., 12: 123 131.

Zubair, A Malik, J Ahmad. Clinico-bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in North India. Biol Med. 2010;2(4):22–34.

AK Pappu, A Sinha, A Johnson. Microbiological profile of diabetic foot ulcer. Calicut Med Journal. 2011;9(3):e1–4.

Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC. A clinicomicrobiological study of diabetic foot ulcers in an Indian tertiary care hospital. DiabetesCare. 2006;29(8):1727–32.

Shanker EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR. Bacterial etiology of diabetic foot infection in south India. Eur J Int Med. 2005; 16:567–70.

E Bansal, A Garg, S Bhatia, AK Attri, J Chander. Spectrum of microbial flora in diabetic foot ulcers. Indian J PatholMicrobiol. 2008 Apr-Jun;51(2):204-8.

Dhanasekaran G, Sastry G, Viswanathan M, Microbial pattern of soft-tissue infections in diabetic patients in South India. Asian J Diabet. 2003; 5:8-10.‏‏